Folgen
JoEllyn McMillan
Titel
Zitiert von
Zitiert von
Jahr
Diagnostics for SARS-CoV-2 infections
BD Kevadiya, J Machhi, J Herskovitz, MD Oleynikov, WR Blomberg, ...
Nature materials 20 (5), 593-605, 2021
7032021
Sequential LASER ART and CRISPR treatments eliminate HIV-1 in a subset of infected humanized mice
PK Dash, R Kaminski, R Bella, H Su, S Mathews, TM Ahooyi, C Chen, ...
Nature communications 10 (1), 1-20, 2019
2892019
Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroAIDS
H Dou, CB Grotepas, JEM McMillan, CJ Destache, M Chaubal, J Werling, ...
The Journal of immunology 183 (1), 661-669, 2009
2442009
Cell delivery of therapeutic nanoparticles
JE McMillan, E Batrakova, HE Gendelman
Progress in molecular biology and translational science 104, 563-601, 2011
1512011
NanoART synthesis, characterization, uptake, release and toxicology for human monocyte–macrophage drug delivery
AS Nowacek, RL Miller, JE McMillan, G Kanmogne, M Kanmogne, ...
Nanomedicine 4 (8), 903-917, 2009
1392009
Analyses of nanoformulated antiretroviral drug charge, size, shape and content for uptake, drug release and antiviral activities in human monocyte-derived macrophages
AS Nowacek, S Balkundi, JE McMillan, U Roy, A Martinez-Skinner, ...
Journal of controlled release 150 (2), 204-211, 2011
1252011
Nanoneuromedicines for degenerative, inflammatory, and infectious nervous system diseases
HE Gendelman, V Anantharam, T Bronich, S Ghaisas, H Jin, ...
Nanomedicine: Nanotechnology, Biology and Medicine 11 (3), 751-767, 2015
1232015
Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice
PK Dash, HE Gendelman, U Roy, S Balkundi, Y Alnouti, RL Mosley, ...
Aids 26 (17), 2135-2144, 2012
1212012
Aroclor 1254 as an antagonist of the teratogenicity of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin
JM Haake, S Safe, K Mayura, TD Phillips
Toxicology letters 38 (3), 299-306, 1987
1191987
Nanoformulated antiretroviral drug combinations extend drug release and antiretroviral responses in HIV-1-infected macrophages: implications for neuroAIDS therapeutics
AS Nowacek, JE McMillan, R Miller, A Anderson, B Rabinow, ...
Journal of neuroimmune pharmacology 5, 592-601, 2010
1172010
Creation of a long-acting nanoformulated dolutegravir
B Sillman, AN Bade, PK Dash, B Bhargavan, T Kocher, S Mathews, H Su, ...
Nature communications 9 (1), 443, 2018
1102018
Covalent binding of the flavonoid quercetin to human serum albumin
MI Kaldas, UK Walle, H Van Der Woude, JEM McMillan, T Walle
Journal of agricultural and food chemistry 53 (10), 4194-4197, 2005
1102005
Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human …
P Puligujja, JE McMillan, L Kendrick, T Li, S Balkundi, N Smith, ...
Nanomedicine: Nanotechnology, Biology and Medicine 9 (8), 1263-1273, 2013
972013
Development of HIV reservoir targeted long acting nanoformulated antiretroviral therapies
B J Edagwa, T Zhou, JE M McMillan, XM Liu, H E Gendelman
Current medicinal chemistry 21 (36), 4186-4198, 2014
942014
Creation of a nanoformulated cabotegravir prodrug with improved antiretroviral profiles
T Zhou, H Su, P Dash, Z Lin, BLD Shetty, T Kocher, A Szlachetka, ...
Biomaterials 151, 53-65, 2018
932018
Bench-to-bedside translation of magnetic nanoparticles
D Singh, JEM McMillan, AV Kabanov, M Sokolsky-Papkov, ...
Nanomedicine 9 (4), 501-516, 2014
912014
Development of mannose-anchored thiolated amphotericin B nanocarriers for treatment of visceral leishmaniasis
G Shahnaz, BJ Edagwa, JE McMillan, S Akhtar, A Raza, NA Qureshi, ...
Nanomedicine 12 (2), 99-115, 2017
822017
A year-long extended release nanoformulated cabotegravir prodrug
TA Kulkarni, AN Bade, B Sillman, BLD Shetty, MS Wojtkiewicz, N Gautam, ...
Nature materials 19 (8), 910-920, 2020
802020
Long-acting slow effective release antiretroviral therapy
B Edagwa, JE McMillan, B Sillman, HE Gendelman
Expert opinion on drug delivery 14 (11), 1281-1291, 2017
772017
Neurotheranostics as personalized medicines
BD Kevadiya, BM Ottemann, MB Thomas, I Mukadam, S Nigam, ...
Advanced Drug Delivery Reviews 148, 252-289, 2019
762019
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20